Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Neurodegenerative Disease

Parkinsonian worms may hold the key to identifying drugs for Parkinson’s disease

Researchers at The University of Texas at Austin have devised a simple test, using dopamine-deficient worms, for identifying drugs that may help people with Parkinson’s disease.

The worms are able to evaluate as many as 1,000 potential drugs a year. The researchers have received federal funding that could increase that to one million drug… Parkinsonian worms may hold the key to identifying drugs for Parkinson’s disease   



Gene for Lou Gehrig’s Disease and Frontotemporal Dementia Identified

Frontotemporal dementia and amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease -  two fatal neurodegenerative disease with distinct symptoms - are triggered by a common mutation in many cases, according to researchers who say they have identified the mutated gene.

In the study, reported in the September 21 online issue of Neuron,… Gene for Lou Gehrig’s Disease and Frontotemporal Dementia Identified   



Positive attitude helps in Parkinson’s battle

Parkinson’s Disease, a neurodegenerative disease, is often characterized by a variety of changes that can affect everyday life.

With symptoms ranging from tremors, difficulty with balance, and slowing of activities, Parkinson’s can threaten to alter the quality of life of almost 100,000 Canadians living with the disease. However, for one Kingston family, a Parkinson’s… Positive attitude helps in Parkinson’s battle   



Parkinson’s breakthough could slow disease progression

In an early-stage breakthrough, a team of Northwestern University scientists has developed a new family of compounds that could slow the progression of Parkinson’s disease.

Parkinson’s, the second most common neurodegenerative disease, is caused by the death of dopamine neurons, resulting in tremors, rigidity and difficulty moving. Current treatments target the symptoms but do… Parkinson’s breakthough could slow disease progression   



Berkeley Lab Scientists Help Develop Promising Therapy for Huntington’s Disease

There’s new hope in the fight against Huntington’s disease. A group of researchers that includes scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have designed a compound that suppresses symptoms of the devastating disease in mice.

The compound is a synthetic antioxidant that targets mitochondria, an organelle within cells… Berkeley Lab Scientists Help Develop Promising Therapy for Huntington’s Disease   



Research uncovers a potential link between Parkinson’s and visual problems

The most common genetic cause of Parkinson’s is not only responsible for the condition’s distinctive movement problems but may also affect vision, according to new research by scientists at the University of York.

Parkinson’s, the second most common form of neurodegenerative disease, principally affects people aged over 60. Its most common symptom is tremor… Research uncovers a potential link between Parkinson’s and visual problems   



People with Parkinson’s strengthen their balance

Leading classes to help people with Parkinson’s disease to do better with their flexibility and balance is something Anthony Krumbholz does in part to honor his father.

Krumbholz, a 34-year-old Muscatine firefighter, leads Delay the Disease classes at the Muscatine Community Y twice each week. His father, John, who lives with Parkinson’s disease, is… People with Parkinson’s strengthen their balance   



International collaboration finds 11 new Alzheimer’s genes to target for drug discovery

University of Miami Miller School of Medicine researchers played a key role in the largest international Alzheimer’s disease genetics collaboration to date, which identified 11 new regions of the genome that contribute to late-onset Alzheimer’s disease, doubling the number of potential genetics-based therapeutic targets to investigate. Published October 27 in Nature Genetics, the… International collaboration finds 11 new Alzheimer’s genes to target for drug discovery   



Scientists uncover how molecule protects brain cells in Parkinson’s disease model

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found how a widely known but little-studied enzyme protects brain cells in models of Parkinson’s disease.

These findings could provide valuable insight into the development of drug candidates that could protect brain cells in Parkinson’s and other neurodegenerative diseases.

The study, published… Scientists uncover how molecule protects brain cells in Parkinson’s disease model   



Living with dementia

cognitive processes2 - decline in cognitive functioning1 - arthritis1 - dementia in elderly1 - sporadic parkinson's disease1 - elderly people1 - vascular risk factors2 - α-synuclein2 - progression of pd1 - diet control1 - difficulties with speech1 - initiative1 - oral health1 - early stage alzheimers1 - postoperative cognitive dysfunction1 - brain insulin1 - motor deficits1 - transient ischaemic attack1 - early signs of dementia1 - chronic sleep deprivation1 - cognitive changes1 - ucla1 - dementia types1 - amyloid beta8 - tau3 - development of parkinson's1 - meryl streep1 - neel nabar1 - presenile-onset disease1 - phosphorylated alpha-synuclein1 -